Foundations Investment Advisors LLC bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 552 shares of the biotechnology company’s stock, valued at approximately $221,000.
A number of other large investors have also made changes to their positions in the company. Mather Group LLC. grew its position in Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after purchasing an additional 27 shares in the last quarter. CWM LLC grew its holdings in shares of Axon Enterprise by 1.3% during the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after buying an additional 36 shares in the last quarter. SPC Financial Inc. raised its position in Axon Enterprise by 2.2% during the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after buying an additional 38 shares during the period. Dorsey Wright & Associates lifted its stake in Axon Enterprise by 0.3% in the 2nd quarter. Dorsey Wright & Associates now owns 14,053 shares of the biotechnology company’s stock worth $4,135,000 after acquiring an additional 39 shares in the last quarter. Finally, Avantax Advisory Services Inc. boosted its position in Axon Enterprise by 0.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after acquiring an additional 40 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.
Axon Enterprise Stock Up 0.3 %
AXON opened at $444.52 on Friday. The firm has a market cap of $33.55 billion, a P/E ratio of 129.98, a price-to-earnings-growth ratio of 12.05 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The business has a 50 day moving average price of $396.09 and a 200 day moving average price of $336.52. Axon Enterprise, Inc. has a twelve month low of $199.29 and a twelve month high of $455.17.
Analyst Ratings Changes
AXON has been the subject of a number of research analyst reports. Northland Securities increased their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Robert W. Baird increased their target price on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $400.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Barclays boosted their target price on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $382.85.
Get Our Latest Stock Report on AXON
Insider Buying and Selling at Axon Enterprise
In other news, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 371,172 shares of company stock worth $137,000,162 over the last ninety days. Company insiders own 6.10% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- Why Invest in High-Yield Dividend Stocks?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to buy stock: A step-by-step guide for beginnersÂ
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Canadian Penny Stocks: Can They Make You Rich?
- MarketBeat Week in Review – 10/21- 10/25
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.